Lamotrigine monotherapy for newly diagnosed typical absence seizures in children
Open Access
- 7 September 2008
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 82 (2-3) , 124-132
- https://doi.org/10.1016/j.eplepsyres.2008.07.016
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Lamotrigine as an add-on drug in typical absence seizuresActa Neurologica Scandinavica, 2009
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Predictors of Lamotrigine‐associated RashEpilepsia, 2006
- Childhood Absence Epilepsy: Evolution and Prognostic FactorsEpilepsia, 2005
- Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescentsPublished by Wiley ,2005
- Lamotrigine versus Valproic Acid as First‐line Monotherapy in Newly Diagnosed Typical Absence Seizures: An Open‐label, Randomized, Parallel‐group StudyEpilepsia, 2004
- Treatment of Typical Absence Seizures and Related Epileptic SyndromesPediatric Drugs, 2001
- Accidental Injury Is a Serious Risk in Children With Typical Absence EpilepsyArchives of Neurology, 1996
- Reliability of the Harter Self-Perception Profile for Children and Predictors of Global Self-WorthThe Journal of Genetic Psychology, 1994
- SIMULTANEOUS RECORDING OF ABSENCE SEIZURES WITH VIDEO TAPE AND ELECTROENCEPHALOGRAPHYBrain, 1975